Integra Lifesciences Holdings (IART) Change in Inventory (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Change in Inventory of $4.3 million for Q1 2026, down 68.39% on a YoY basis from $13.7 million in Q1 2025, and up 29.57% sequentially from $3.3 million in Q4 2025.
Integra Lifesciences Holdings (IART) Change in Inventory (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 18 years of Change in Inventory data on file, last reported at $4.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 68.39% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $37.4 million (up 63.83% YoY), and the FY2025 full-year result was $46.8 million, up 66.12% from the prior year.
- Change in Inventory advanced to $4.3 million in Q1 2026, from $3.3 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $25.4 million in Q1 2023 to a low of -$1.7 million in Q2 2024.
- A 5-year average of $9.9 million and a median of $6.9 million in 2022 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory sank 181.75% in 2024 and soared 486.14% in 2025, its largest moves.
- Tracing IART's Change in Inventory over 5 years: stood at $4.7 million in 2022, then surged by 250.84% to $16.4 million in 2023, then slumped by 96.53% to $570000.0 in 2024, then soared by 486.14% to $3.3 million in 2025, then rose by 29.57% to $4.3 million in 2026.
- Business Quant data shows IART's Change in Inventory at $4.3 million in Q1 2026, $3.3 million in Q4 2025, and $23.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn | 4.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.33 Mn |
| Mar 31, 2026 | 4.33 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Sep 30, 2025 | 23.35 Mn |
| Sep 30, 2025 | 23.35 Mn |
| Jun 30, 2025 | 6.38 Mn |
| Jun 30, 2025 | 6.38 Mn |
| Mar 31, 2025 | 13.70 Mn |
| Mar 31, 2025 | 13.70 Mn |
| Dec 31, 2024 | 570,000.00 |
| Dec 31, 2024 | 570,000.00 |
| Sep 30, 2024 | 10.30 Mn |
| Sep 30, 2024 | 10.30 Mn |
| Jun 30, 2024 | -1.74 Mn |
| Jun 30, 2024 | -1.74 Mn |
| Mar 31, 2024 | 19.02 Mn |
| Mar 31, 2024 | 19.02 Mn |
| Dec 31, 2023 | 16.42 Mn |
| Dec 31, 2023 | 16.42 Mn |